Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sue Moss

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 17, 2007
The effect of mammographic screening and hormone replacement therapy use on breast cancer incidence in England and WalesMichael Waller, Sue Moss, Joanna Watson, et al.
European Urology|July 8, 2015
Corrigendum to "Incidence of Prostate Cancer After Termination of Screening in a Population-based Randomised Screening Trial" [Eur Urol 2013;64:703-9]Anna Grenabo Bergdahl, Erik Holmberg, Sue Moss, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|July 23, 2005
The development of a quality assurance programme for HPV testing within the UK NHS cervical screening LBC/HPV studiesHeather A Cubie, Catherine Moore, Michael Waller, et al.
European Urology|June 1, 2013
Incidence of prostate cancer after termination of screening in a population-based randomised screening trialAnna Grenabo Bergdahl, Erik Holmberg, Sue Moss, et al.
Journal of Clinical Pathology|January 11, 2011
A practical application of analysing weighted kappa for panels of experts and EQA schemes in pathologyKaren C Wright, Patricia Harnden, Sue Moss, et al.
BMJ (Clinical Research Ed.)|January 10, 2006
Effect of testing for human papillomavirus as a triage during screening for cervical cancer: observational before and after studySue Moss, Alastair Gray, Rosa Legood, et al.
Lancet (London, England)|May 2, 2015
Prostate cancer screening in Europe - Authors' replyFritz Schröder, Jonas Hugosson, Sigrid Carlsson, et al.
BMJ (Clinical Research Ed.)|May 29, 2004
Psychological impact of human papillomavirus testing in women with borderline or mildly dyskaryotic cervical smear test results: cross sectional questionnaire studyEsther Maissi, Theresa M Marteau, Matthew Hankins, et al.
Histopathology|October 22, 2011
Evaluation of the use of digital images for a national prostate core external quality assurance schemePatricia Harnden, Derek Coleman, Sue Moss, et al.
Journal of Medical Screening|September 14, 2012
Breast cancer mortality in mammographic screening in Europe: a review of incidence-based mortality studiesSisse Njor, Lennarth Nyström, Sue Moss, et al.
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 17, 2007
The effect of mammographic screening and hormone replacement therapy use on breast cancer incidence in England and WalesMichael Waller, Sue Moss, Joanna Watson, et al.
European Urology|July 8, 2015
Corrigendum to "Incidence of Prostate Cancer After Termination of Screening in a Population-based Randomised Screening Trial" [Eur Urol 2013;64:703-9]Anna Grenabo Bergdahl, Erik Holmberg, Sue Moss, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|July 23, 2005
The development of a quality assurance programme for HPV testing within the UK NHS cervical screening LBC/HPV studiesHeather A Cubie, Catherine Moore, Michael Waller, et al.
European Urology|June 1, 2013
Incidence of prostate cancer after termination of screening in a population-based randomised screening trialAnna Grenabo Bergdahl, Erik Holmberg, Sue Moss, et al.
Journal of Clinical Pathology|January 11, 2011
A practical application of analysing weighted kappa for panels of experts and EQA schemes in pathologyKaren C Wright, Patricia Harnden, Sue Moss, et al.
BMJ (Clinical Research Ed.)|January 10, 2006
Effect of testing for human papillomavirus as a triage during screening for cervical cancer: observational before and after studySue Moss, Alastair Gray, Rosa Legood, et al.
Lancet (London, England)|May 2, 2015
Prostate cancer screening in Europe - Authors' replyFritz Schröder, Jonas Hugosson, Sigrid Carlsson, et al.
BMJ (Clinical Research Ed.)|May 29, 2004
Psychological impact of human papillomavirus testing in women with borderline or mildly dyskaryotic cervical smear test results: cross sectional questionnaire studyEsther Maissi, Theresa M Marteau, Matthew Hankins, et al.
Histopathology|October 22, 2011
Evaluation of the use of digital images for a national prostate core external quality assurance schemePatricia Harnden, Derek Coleman, Sue Moss, et al.
Journal of Medical Screening|September 14, 2012
Breast cancer mortality in mammographic screening in Europe: a review of incidence-based mortality studiesSisse Njor, Lennarth Nyström, Sue Moss, et al.
Pageof 6